Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Otago researchers in major new study of TB and diabetes

Otago researchers in major new study of TB and diabetes epidemics

University of Otago expertise is set to play a key role in European Commission (EC) funded research into links between infectious and non-communicable diseases – in this case tuberculosis (TB) and type 2 diabetes.

The EC has earmarked €6 billion for health research under its Seventh Framework Programme (FP7) for the funding of research and technological development, of which €6 million (NZ$9.5 million) has been awarded to the new project.

Co-Director of the University’s Centre for International Health, Professor Philip Hill, says the initial call was for projects that combine one of the three major poverty-related diseases – HIV/AIDS, malaria and tuberculosis – with the major non-infectious diseases including rheumatic or cardiovascular disease, cancer and diabetes.

“This year nine million people will be diagnosed with TB and up to 1.4 million will die from it. We also know that just under 400 million people live with diabetes and around 10 - 20% of new cases of TB are also diabetic, which is a much higher percentage than you would expect by chance,” Professor Hill says.

“There are more TB cases with diabetes than there are with HIV and while diabetes doesn't have as dramatic an effect on TB as HIV does, it is clearly a significant player - presumably through an effect on the immune system. The fact that the number of people worldwide with diabetes is increasing at an alarming rate will have an effect on global TB control.”

Professor Hill, who has an extensive record in TB research in developing countries, will be part of a multi-disciplinary consortium linking field sites in four TB-endemic countries that are experiencing a rapid growth of type 2 diabetes – namely Romania, Peru, South Africa and Indonesia.

The €6 million (NZ$9.5 million) project, which will be known as TANDEM (Tuberculosis and Diabetes ­Mellitus), will see Otago researchers collaborating with leading laboratories in Germany, UK, Netherlands and Romania. The project’s official start date is 1 February 2013.

The consortium’s aim is to increase knowledge of the causative links between the two diseases and by doing that develop better prevention, treatment and management of them so that mortality rates can be reduced and quality of life improved.

Professor Hill, who was part of the team that designed the study, says the consortium wants to test the hypothesis that screening and management can be greatly improved and simplified with a major impact on the control of TB and diabetes co-morbidity.

“We will explore how best to screen people with TB for diabetes and we will also be able to give an indication, across continents, of the actual proportion of TB patients who also have diabetes, and their basic characteristics.”

TANDEM will also examine the best medications and treatments for TB in this group of patients and explore what their long-term requirements are in terms of diabetes treatment once they have finished their TB treatment.

The study will also look at the effect of glucose control on TB treatment outcome and also look for immune system abnormalities and genetic variations common to both diseases.

Professor Hill says one of the great plusses of a multi-site study like this is the greater statistical power it provides. The researchers will end up with 1500 - 2000 TB cases to study and of those, around 350-400 will also have diabetes.

Otago will be particularly involved in the study based in Indonesia, as part of their formal collaboration with Padjadjaran University, and that study alone will provide about 400 TB cases.

“It is a great privilege to be involved in a European Union study,” says Professor Hill.

“We couldn’t apply on our own; we needed to be part of a consortium and offer something that is not easily available within the EU. Our previous field studies in TB and our growing collaboration with Padjadjaran University provides that.”

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Interest Rates: RBNZ Hikes OCR To 3.5%, ‘Period Of Assessment’ Now Needed

Reserve Bank governor Graeme Wheeler raised the official cash rate as expected, while signalling a pause in rate hikes to assess the impact of moves so far this year. The kiwi dollar sank after Wheeler said its strength was “unjustified” and that the currency could have “a significant fall.” More>>

ALSO:

Fonterra: Canpac Site 'Resize' To Focus More On Paediatrics

Fonterra is looking at realigning its packing operations at Canpac, in the Waikato, to focus more on paediatric nutritionals... The proposed changes could mean around 110 roles may not be required at the site which currently employs 330. More>>

ALSO:

Scoop Business: Postie Plus Brand Gets 2nd Chance With Well-Funded Pepkor

The Postie Plus brand is getting a new lease of life after South Africa’s Pepkor bought the failed retailer’s assets out of administration and said it will use its purchasing power to reduce costs of stock and fatten margins. More>>

ALSO:

Warming: Warming Signs From State Of Climate Report

Climate data from air, land, sea and ice in 2013 'reflect trends of a warming planet' -- says the latest State of the Climate report, launched by U.S. and New Zealand scientists. More>>

ALSO:

Scoop Business: Embrace Falling Home Affordability, Says NZIER

Despair over the inability to afford a house is misplaced and should be embraced as an opportunity to invest in more wealth-creating activity, says the principal economist at the New Zealand Institute of Economic Research, Shamubeel Eaqub. More>>

Productivity Commission: NZ Regulation Not Keeping Pace

New Zealand regulators often have to work with out-of-date legislation, quality checks are under strain, and regulatory workers need better training and development. More>>

ALSO:

Callaghan Innovation: Investment To Help Deepen Innovation Reporting

Callaghan Innovation, the government’s high tech HQ for Kiwi business, is to help deepen New Zealand media coverage of the commercialisation of innovation through an arms-length partnership with independent business news service BusinessDesk. More>>

ALSO:

Tax Credits, Grants: Greens $1Bn R&D Plan

In the Party’s headline economic announcement, the Greens have launched their plan to build a smarter, more innovative economy which has as its centrepiece an additional $1 billion of government investment in research and development (R&D) above current spend, including tax breaks for business. More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news